Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6535
    +0.0012 (+0.18%)
     
  • OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD

    2,349.60
    +7.10 (+0.30%)
     
  • Bitcoin AUD

    96,332.99
    -2,357.10 (-2.39%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • AUD/EUR

    0.6108
    +0.0035 (+0.57%)
     
  • AUD/NZD

    1.0994
    +0.0037 (+0.33%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Analysts’ Recommendations on Carlyle, Pre-4Q17 Results

Analysts’ Recommendations on Carlyle, Pre-4Q17 Results

Of the 12 analysts covering The Carlyle Group (CG) in January 2018, four have recommended “strong buy,” five have recommended “hold,” and three have recommended “buy.” There have been no “sell” or “strong sell” recommendations for the past few months. Of the nine analysts covering Federated Investors (FII) in January 2018, five have recommended “hold,” one has recommended “sell,” and three have recommended “strong sell.” There were no “strong buy” or “buy” recommendations. Of the eight analysts covering Carlyle’s competitor (XLF), Brookfield Asset Management (BAM), in January 2018, five have recommended “strong buy,” two have recommended “buy,” and one has recommended “hold.” Of the 11 analysts covering Ameriprise Financial (AMP) in January 2018, three have recommended “strong buy,” three have recommended “buy,” and five have recommended “hold.” There were no “sell” or “strong sell” recommendations.